[1] Le Poole IC, van den Wijngaard RM, Westerhof W, et al. Presence or absence of melanocytes in vitiligo lesions:an immunohistochemical investigation. J Invest Dermatol, 1993,100:816-822. [2] Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol, 1991,97:1078-1080. [3] Song YH, Connor E, Li Y, Zorovich B, et al. The role of tyrosinase in autoimmune vitiligo. Lancet, 1994,344(8929):1049-1052. [4] 李志强,高天文,马翠玲,等.白癜风患者血清中抗黑素细胞抗体IgG、IgM抗体的检测及补体介导的血清细胞毒反应.临床皮肤科杂志,2000,29:136-138. [5] Hann SK, Shin HK, Park SH, et al. Detection of antibodies to melanocytes in vitiligo by Western immunoblotting. Yonsei Med J,1996,37:365-370. [6] 李志强,高天文,赵小东,等.白癜风患者血清中抗黑素细胞表面抗原自身抗体检测.中华皮肤科杂志,2001,34:268-270. [7] Cui J, Harning R, Henn M, et al. Identification of pigment cell antigens defined by vitiligo antibodies.J Invest Dermatol, 1992,98:162-165. [8] Hara I, Takechi Y, Houghton AN. Implicating a role for immune recognition of self in tumor rejection:passive immunization against the brown locus protein. J Exp Med, 1995,182:1609-1614. [9] Cui J, Arita Y, Bystryn JC. Characterization of vitiligo antigens. Pigment Cell Res, 1995,8:53-59. |